Fresenius Kabi Expands Pediatric Parenteral Nutrition Portfolio with Pedismof Range

Strengthening Pediatric Nutrition Care Across Europe

Fresenius Kabi AG has expanded its line of pediatric parenteral feeding solutions by introducing its Pedismof range throughout Europe. The ready-to-use three-chamber bags are specifically intended for preterm infants, neonates, toddlers, and adolescents who require intravenous nutritional support when oral or enteral feeding is not possible. By offering standardized formulations that save preparation times and increase dosage accuracy, the launch seeks to streamline clinical procedures. Additionally, it helps medical practitioners provide uniform nutritional therapy in pediatric and neonatal intensive care units. The children pediatric clinical nutrition.

Enhancing Clinical Nutrition with Ready-to-Use Formulation

The increased need for standardized pediatric nutrition products that increase treatment effectiveness and lower the possibility of preparation errors is reflected in the Pedismof line. The novel formulations reduce handling complexity in newborn and pediatric intensive care units while assisting medical professionals in providing precise nutritional support. Furthermore, the ready-to-use package promotes better administration techniques in hospital settings and reduces the danger of contamination. Additionally, the launch is in line with the growing emphasis on individualized nutritional treatment for children who are at risk and need ongoing nutritional support. It is anticipated that these developments will facilitate the adoption of novel parenteral nutrition options and enhance patient outcomes.

According to Precedence Research, the global Parenteral Nutrition Market size was calculated at USD 7.67 billion in 2025 and is projected to increase from USD 8.14 billion in 2026 to approximately USD 13.91 billion by 2035, expanding at a CAGR of 6.13% from 2026 to 2035, driven by the rising prevalence of chronic diseases, increasing premature births, growing demand for clinical nutrition, and continuous advancements in parenteral nutrition formulations.

Industry Impact and Market Outlook

The European introduction of the Pedismof range demonstrates the industry's increasing focus on specialized pediatric nutrition and ready-to-use intravenous formulations. As hospitals continue to prioritize patient safety, treatment efficiency, and personalized nutritional care, manufacturers are expanding their clinical nutrition portfolios with advanced products. Growing demand for neonatal and pediatric nutritional support is expected to encourage further investments in innovative formulations and delivery technologies. Moreover, the introduction of specialized products such as Pedismof is likely to strengthen competition and accelerate product development across the global parenteral nutrition market.